Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Oxycodone
(D05312)		1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 46, 298 💬
2Oxycodone depot ”sandoz”, depot tablets
(D05312)		1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 298 💬
3Oxycodone hydrochloride
(D05312)		1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬4件: 6, 70, 226, 298 💬
4Oxycodone naloxone prolonged release tablets
(D05312)		1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
5Oxycodone orion
(D05312)		1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 70 💬
6Oxycodone/acetaminophen
(D05312)		1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 231 💬
7Oxycodone/naloxone prolonged release T
(D05312)		2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
8Oxycodone/naloxone prolonged release tablets
(D05312)		1件: Oxycodone3件: Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
9Oxycodone/naloxone prolonged release tablets 10 MG /5 MG
(D05312)		2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
10Oxycodone/naloxone prolonged release tablets 10/5 MG
(D05312)		2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
11Oxycodone/naloxone prolonged release tablets 20 MG /10 MG
(D05312)		2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
12Oxycodone/naloxone prolonged release tablets 20/10 MG
(D05312)		2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
13Oxycodone/naloxone prolonged release tablets 5 MG /2.5 MG
(D05312)		2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
14Oxycodone/naloxone prolonged release tablets 5/2.5 MG
(D05312)		2件: Naloxone,
Oxycodone		6件: Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 226 💬
15PR oxycodone
(D05312)		----1件: 6 💬